Trial Profile

A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Apr 2024 Results assessing Efficacy of Low-sodium Oxybate by Baseline Sleep Inertia in Participants with Idiopathic Hypersomnia presented at the 76th Annual Meeting of the American Academy of Neurology 2024
18 Apr 2024 Results (n=109) Minimal Clinically Important Difference for the Visual Analog Scale for Sleep Inertia presented at the 76th Annual Meeting of the American Academy of Neurology 2024
23 Oct 2023 Results of exploratory, post-hoc analysis presented in the Jazz Pharmaceuticals Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com